Donor lymphocyte infusion for post-transplant relapse of Hodgkin's lymphoma

被引：0
|
作者：
De Rosa, G
Pezzullo, L
Scarpato, N
Selleri, C
Lucania, A
Rotoli, B
机构：
[1] Univ Naples Federico II, Div Hematol, I-80131 Naples, Italy
[2] Univ Naples Federico II, Serv Immunohematol, I-80131 Naples, Italy
来源：
HAEMATOLOGICA | 2000年 / 85卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
We report the case of a patient with poor prognosis Hodgkin's disease who received an allogeneic transplant, relapsed after a few months, and was rescued by salvage treatment followed by donor lymphocyte infusion.
引用
收藏
页码：780 / 781
页数：2
相关论文
共 50 条
  • [31] Recommendations for reporting post-transplant relapse in AML
    A Rashidi
    M A Linden
    M-E Percival
    B M Sandmaier
    S Devine
    D J Weisdorf
    Bone Marrow Transplantation, 2018, 53 : 111 - 113
  • [32] Different response to salvage chemotherapy but similar post-transplant outcomes in patients with relapsed and refractory Hodgkin's lymphoma
    Puig, Noemi
    Pintilie, Melania
    Seshadri, Tara
    al-Farsi, Khalil
    Nagy, Tracy
    Franke, Norman
    Tsang, Richard
    Keating, Armand
    Crump, Michael
    Kuruvilla, John
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (09): : 1496 - 1502
  • [33] Post-transplant plasmablastic lymphoma of the skin
    Nicol, I
    Boye, T
    Carsuzaa, F
    Feier, L
    Villette, AMC
    Xerri, L
    Grob, JJ
    Richard, MA
    BRITISH JOURNAL OF DERMATOLOGY, 2003, 149 (04) : 889 - 891
  • [34] Post-transplant plasmablastic lymphoma of the skin
    Black, Catherine L.
    Foster-Smith, Erwin
    Lewis, Ian D.
    Faull, Randall J.
    Sidhu, Shireen K.
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2013, 54 (04) : 277 - 282
  • [35] Withdrawal of post-transplant immunosuppression and donor lymphocyte infusion associated to dasatinib led to chimerism recovery and reduction in levels of Bcr-Abl transcript in early chronic myeloid leukaemia relapse
    Parma, M.
    Passerini, C. Gambacorti
    Pioltelli, P.
    Colnaghi, F.
    Colombo, A.
    Terruzzi, E.
    Elli, E.
    Perfetti, P.
    Pogliani, E. M.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S438 - S439
  • [36] A PILOT TRIAL OF WTI PEPTIDE-LOADED ALLOGENEIC DENDRITIC CELL (DC) VACCINATION AND DONOR LYMPHOCYTE INFUSION (DLI) FOR WTI-EXPRESSING HEMATOLOGIC MALIGNANCIES AND POST-TRANSPLANT RELAPSE
    Shah, N. N.
    Loeb, D.
    Khuu, H.
    Stroncek, D.
    Raffeld, M.
    Delbrook, C.
    Richards, K.
    Baird, K.
    Levine, J.
    Leitman, S.
    Mackall, C. L.
    Fry, T. J.
    Wayne, A. S.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (02) : S259 - S260
  • [37] Dose-escalated donor lymphocyte infusions post allogeneic transplantation in non-Hodgkin's lymphoma
    Bloor, AJC
    Thomson, K
    Cooper, N
    Peggs, KS
    Mackinnon, S
    BLOOD, 2005, 106 (11) : 569A - 570A
  • [38] Donor-lymphocyte infusion (DLI) after hematopoietic stem cell transplantation with post-transplant cyclophosphamide (PTCY) as GVHD prevention treatment
    Gallo, Susanna
    Caravelli, Daniela
    Becco, Paolo
    Polo, Alessandra
    Salierno, Milena
    Giancaspero, Karol
    Scalabrini, Delia Rota
    Sangiolo, Dario
    Vassallo, Elena
    Frascione, Pio Manlio Mirko
    Poletto, Stefano
    Paruzzo, Luca
    Crotto, Luca
    Aglietta, Massimo
    Fagioli, Franca
    Schianca, Fabrizio Carnevale
    BONE MARROW TRANSPLANTATION, 2019, 54 : 189 - 190
  • [39] Immunomodulation by escalated lymphodepletion and donor lymphocyte infusion to treat post-allogeneic transplantation relapse
    Guillaume, T.
    Gaugler, B.
    Chevallier, P.
    Delaunay, J.
    Ayari, S.
    Moreau, P.
    Mohty, M.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S319 - S320
  • [40] Passenger Lymphocyte Syndrome in Post-Transplant Patients
    Memon, Aliza Anwar
    Fleetwood, Vidya
    Hermelin, Daniela
    Malvik, Natalie
    Caliskan, Yasar
    Bastani, Bahar
    Abu Al Rub, Fadee
    Vo, Thanh-Mai N.
    Edwards, John C.
    Lentine, Krista L.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 839 - 839
12345